Info

Ribomed Biotechnologies, Inc. is developing assays for the early detection and monitoring of disease utilizing its patented, isothermal molecular detection process, Abscription®. Ribomed develops products for the detection of DNA, RNA, protein and CpG methylation, with our current focus on the following two types of epigenetic changes:Methylation changes in regulatory regions of DNA and histones that cause silencing of protective genes, such as tumor suppressors or activation of disease initiating genes. Changes in expression of small micro RNAs (miRNA) that regulate the levels of proteins involved in disease initiation and expression, particularly those related to cancer and type 2 diabetes. Ribomed Products:Dinucleotides: We offer a variety of dinucleotides. Dinucleotides are available in 5 and 10 micromole sizes. Ribo-MET: Ribo-MET is a product line for the detection of changes in methylation levels of genes and histones. Ribo-miRNA: Ribo-miRNA kits are for the detection of multiple small RNA molecules involved in inhibition of gene expression and associated with the onset of disease. CLICK HERE for more on Ribomed Products